|
|
||||
html xmlns=http://www.w3.org/1999/xhtmlbody
table border= trtd
p
EQSNews: Drägerwerk AG & Co. KGaA
/ Key words: Quarter Results/Forecast
br/
Drägerwerk AG & Co. KGaA: Dräger with strong first quarter in 2026...
Lire...
30/04/2026 07:30
EQS-News: Evotec Receives Grants to Advance Tuberculosis Treatment
html xmlns=http://www.w3.org/1999/xhtmlbody
table border= trtd
p
EQSNews: Evotec SE
/ Key words: Miscellaneous
br/
Evotec Receives Grants to Advance Tuberculosis Treatment br/br/
30.04.2026 / 07:30 CET/CESTbr/
The issuer is solely...
Lire...
html xmlns=http://www.w3.org/1999/xhtmlbody
table border= trtd
p
EQSNews: Baader Bank AG
/ Key words: Quarter Results
br/
Baader Bank Bank reports solid Group earnings before tax in Q1 br/br/
30.04.2026 / 07:30 CET/CESTbr/
The issuer is...
Lire...
30/04/2026 07:30
EQS-News: TAKKT AG: TAKKT starts the year in line with expectations
html xmlns=http://www.w3.org/1999/xhtmlbody
table border= trtd
p
EQSNews: TAKKT AG
/ Key words: Quarterly / Interim Statement
br/
TAKKT AG: TAKKT starts the year in line with expectations br/br/
30.04.2026 / 07:30 CET/CESTbr/
The issuer...
Lire...
30/04/2026 07:30
EQS-News: Circus Accelerates U.S. Market Entry; Acquisition of U.S.-Israelian K-Robotics Completed
html xmlns=http://www.w3.org/1999/xhtmlbody
table border= trtd
p
EQSNews: Circus SE
/ Key words: Acquisition
br/
Circus Accelerates U.S. Market Entry; Acquisition of U.S.Israelian KRobotics Completed br/br/
30.04.2026 / 07:30...
Lire...
html xmlns=http://www.w3.org/1999/xhtmlbodytable border= trtd
p
br/
EQSMedia / 30.04.2026 / 07:30 CET/CESTbr//p
divpbInflection point driven by rising optoelectronics demand/b/p
piFull‑year 2026 guidance raised / Operating cash flow further improved / Q1 results in line with...
Lire...
30/04/2026 07:30
EQS-News: Befesa achieves solid Q1 with adjusted EBITDA +4% YoY to €58m and Net Profit +11% and expects full year EBITDA between €250m and €270m
html xmlns=http://www.w3.org/1999/xhtmlbody
table border= trtd
p
EQSNews: Befesa S.A.
/ Key words: Quarter Results
br/
Befesa achieves solid Q1 with adjusted EBITDA 4% YoY to €58m and Net Profit 11% and expects full year EBITDA between €250m and...
Lire...
30/04/2026 07:30
ORPHAN SYNERGY EUROPE-PHARMA : OSE Immunotherapeutics Reports Full Year 2025 Unaudited Consolidated Financial Results and 2026 Q1 Cash Position
OSE Immunotherapeutics Reports Full Year 2025 Unaudited
Consolidated Financial Results and 2026 Q1 Cash Position
• OSE entered 2026 with a clear 3year strategic roadmap focused on delivering
multiple catalysts for both lusvertikimab and Tedopi® 1
...
Lire...
30/04/2026 07:30
74Software: Double-digit Organic Growth in Q1 2026, with Further Progress Toward Recurring Software Revenue
Press Release
74Software: Doubledigit Organic Growth in Q1 2026, with Further
Progress Toward Recurring Software Revenue
Paris, April 30, 2026 — 74Software Euronext Paris: 74SW reported Q1 2026 revenue of €182.7 million, representing
organic growth of 10.0%. This performance was driven by...
Lire...
|
|
||||